1st Quarter - Report
IPOLICY SOLUTIONS for ASSOCIATION FOR MOLECULAR PATHOLOGY
Firm
Income
$42,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
No bill number, Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage No bill number, Verified Innovative Testing in American Laboratories (VITAL) Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN ANDERSON BROOKS | — |
| JENNIFER RACHEL LEIB | Fellow, Senate Committee on Health, Education, Labor, and Pensions |
Copyright/Patent/Trademark CPT
U.S. Patent Act Sec. 101 Reforms
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN ANDERSON BROOKS | — |
| JENNIFER RACHEL LEIB | Legislative Fellow, Committee on Health, Education, Labor, and Pensions |
Medicare/Medicaid MMM
S.236 - Tracking COVID-19 Variants Act H.R.1946 - To amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN ANDERSON BROOKS | — |
| JENNIFER RACHEL LEIB | Fellow, Senate Committee on Health, Education, Labor, and Pensions |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.